AMANDA MOORE: Open Payments
NPI 1316791387 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,184 in 71 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $278 · 2025 $1,184
Food & beverage: $1,184
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $239 |
| ABBVIE INC. | 11 | $187 |
| PFIZER INC. | 9 | $184 |
| Lilly USA, LLC | 11 | $152 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $88 |
| Amgen Inc. | 3 | $44 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $28 |
Products named: UBRELVY, MOUNJARO, Wegovy, ELIQUIS, CAPLYTA, NURTEC ODT, JARDIANCE, ZORYVE.
Industry payments across KY — which companies pay providers there.
